AJP - Renal Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol 280: F406-F414, 2001;
0363-6127/01 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (52)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nishiyama, A.
Right arrow Articles by Navar, L. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nishiyama, A.
Right arrow Articles by Navar, L. G.
Vol. 280, Issue 3, F406-F414, March 2001

Interactions of adenosine A1 and A2a receptors on renal microvascular reactivity

Akira Nishiyama, Edward W. Inscho, and L. Gabriel Navar

Department of Physiology, Tulane University Health Sciences Center, New Orleans, Louisiana 70112-2699

Adenosine vasoconstricts preglomerular arterioles via adenosine A1 receptors. Because adenosine also activates adenosine A2 receptors, its overall renal vascular actions are complex and not fully understood. The present study was performed to determine the relative contributions of adenosine A1 and A2a receptors to the responsiveness of the renal microvasculature to adenosine. Afferent and efferent arteriolar diameters were monitored in vitro using the blood-perfused rat juxtamedullary nephron preparation. Basal afferent and efferent arteriolar diameters averaged 17.1 ± 0.5 (n = 35) and 17.8 ± 0.5 (n = 20) µm, respectively. Superfusion with 0.1 and 1 µmol/l adenosine did not significantly alter afferent and efferent arteriolar diameters; however, 10 µmol/l adenosine significantly reduced afferent and efferent arteriolar diameters (-8.2 ± 0.8 and -5.7 ± 0.6%, respectively). The afferent and efferent arteriolar vasoconstrictor responses to adenosine waned at a dose of 100 µmol/l, such that diameters returned to values not significantly different from control within 2 min. During adenosine A1 receptor blockade with 8-noradamantan-3-yl-1,3-dipropylxanthine (KW-3902: 10 µmol/l), 10 and 100 µmol/l adenosine significantly increased afferent diameter by, respectively, 8.1 ± 1.2 and 13.7 ± 1.3% (n = 14) and efferent arteriolar diameter by 6.4 ± 1.3 and 9.3 ± 1.2% (n = 8). The afferent and efferent arteriolar vasodilatory responses to adenosine in the presence of KW-3902 were significantly attenuated by addition of the adenosine A2a receptor antagonist 1,3-dipropyl-7-methyl-8-(3,4-dimethoxystyryl)xanthine (KF-17837: 15 µmol/l, n = 7 and 6, respectively). The addition of KF-17837 alone significantly enhanced afferent (n = 15) and efferent (n = 6) arteriolar vasoconstrictor responses to 1, 10, and 100 µmol/l adenosine. These results indicate the presence of adenosine A1 and A2a receptors on afferent and efferent arterioles of juxtamedullary nephrons, such that adenosine A2a receptor-mediated vasodilation partially buffers adenosine-induced vasoconstriction in both pre- and postglomerular segments of the renal microvasculature.

adenosine; afferent arterioles; efferent arterioles; KW-3902; KF-17837


This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
E. L. Liclican, J. C. McGiff, J. R. Falck, and M. A. Carroll
Failure to upregulate the adenosine2A receptor-epoxyeicosatrienoic acid pathway contributes to the development of hypertension in Dahl salt-sensitive rats
Am J Physiol Renal Physiol, December 1, 2008; 295(6): F1696 - F1704.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
V. Vallon, C. Miracle, and S. Thomson
Adenosine and kidney function: Potential implications in patients with heart failure
Eur J Heart Fail, February 1, 2008; 10(2): 176 - 187.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. Patzak, E. Y. Lai, M. Fahling, M. Sendeski, P. Martinka, P. B. Persson, and A. E. G. Persson
Adenosine enhances long term the contractile response to angiotensin II in afferent arterioles
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2007; 293(6): R2232 - R2242.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M.-G. Feng and L. G. Navar
Adenosine A2 Receptor Activation Attenuates Afferent Arteriolar Autoregulation During Adenosine Receptor Saturation in Rats
Hypertension, October 1, 2007; 50(4): 744 - 749.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
Z. Guan, D. A. Osmond, and E. W. Inscho
Purinoceptors in the Kidney
Experimental Biology and Medicine, June 1, 2007; 232(6): 715 - 726.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
V. Vallon, B. Muhlbauer, and H. Osswald
Adenosine and kidney function.
Physiol Rev, July 1, 2006; 86(3): 901 - 940.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
E. L. Liclican, J. C. McGiff, P. L. Pedraza, N. R. Ferreri, J. R. Falck, and M. A. Carroll
Exaggerated response to adenosine in kidneys from high salt-fed rats: role of epoxyeicosatrienoic acids
Am J Physiol Renal Physiol, August 1, 2005; 289(2): F386 - F392.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. Kousai, R. Mizuno, F. Ikomi, and T. Ohhashi
ATP inhibits pump activity of lymph vessels via adenosine A1 receptor-mediated involvement of NO- and ATP-sensitive K+ channels
Am J Physiol Heart Circ Physiol, December 1, 2004; 287(6): H2585 - H2597.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
P. B. Hansen and J. Schnermann
Vasoconstrictor and vasodilator effects of adenosine in the kidney
Am J Physiol Renal Physiol, October 1, 2003; 285(4): F590 - F599.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
E. W. Inscho
Modulation of renal microvascular function by adenosine
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2003; 285(1): R23 - R25.
[Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
P. B. Hansen, S. Hashimoto, J. Briggs, and J. Schnermann
Attenuated renovascular constrictor responses to angiotensin II in adenosine 1 receptor knockout mice
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2003; 285(1): R44 - R49.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Y. Aki, A. Nishiyama, A. Miyatake, S. Kimura, M. Kohno, and Y. Abe
Role of Adenosine A1 Receptor in Angiotensin II- and Norepinephrine-Induced Renal Vasoconstriction
J. Pharmacol. Exp. Ther., October 1, 2002; 303(1): 117 - 123.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
E. K. Jackson, C. Zhu, and S. P. Tofovic
Expression of adenosine receptors in the preglomerular microcirculation
Am J Physiol Renal Physiol, July 1, 2002; 283(1): F41 - F51.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. Nishiyama and L. G. Navar
Response to J. Schnermann: Adenosine mediates tubuloglomerular feedback
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2002; 283(1): Ra278 - Ra280.
[Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
M. D. Okusa
A2A adenosine receptor: a novel therapeutic target in renal disease
Am J Physiol Renal Physiol, January 1, 2002; 282(1): F10 - F18.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
E. K. Jackson and R. K. Dubey
Role of the extracellular cAMP-adenosine pathway in renal physiology
Am J Physiol Renal Physiol, October 1, 2001; 281(4): F597 - F612.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
H. Murer, N. Hernando, I. Forster, and J. Biber
Proximal Tubular Phosphate Reabsorption: Molecular Mechanisms
Physiol Rev, October 1, 2000; 80(4): 1373 - 1409.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
R. Brown, A. Ollerstam, B. Johansson, O. Skott, S. Gebre-Medhin, B. Fredholm, and A. E. G. Persson
Abolished tubuloglomerular feedback and increased plasma renin in adenosine A1 receptor-deficient mice
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2001; 281(5): R1362 - R1367.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online